| 2024/07/16 20:30:22 | |
|---|---|
| Price | |
| 32.075 EUR | |
| Difference | 2.18% (0.69) |
General attributes
| ISIN | US0718131099 |
| Symbol | BAX |
| Exchange | Berlin |
| Currency | EUR |
| Sector | Chemical / Pharmaceutical / Health |
| Security type | Stock |
| Market cap (m) | 16,618 EUR |
| Benchmark | S&P 500 |
Market data
| Bid (Bid size) | - |
| Ask (Ask size) | - |
| Open | 31.20 EUR |
| High | 32.075 EUR |
| Low | 31.14 EUR |
| Close (prev. day) | 31.39 EUR |
| VWAP | - |
| Volume (pcs) | 0 |
| Trading volume | 0.00 |
| Number of trades | 19 |
| Last size | 0 |
Futures and Options
| Related Futures | 15 |
| Related Options | - |
PDF Downloads
| Company report: BAXTER INTERNATIONAL INC |  |
Add Benchmark:
Recent research
| Date | Headline | Download | |
| 2024/07/12 |
|
Global Equity Ratings |
|
| 2024/06/21 |
|
Global Equity Ratings |
|
| 2024/06/14 |
|
Global Equity Ratings |
|
| 2024/05/29 |
|
Global Equity Ratings |
|
| 2024/04/26 |
|
Global Equity Ratings |
|
| 2024/07/16 20:30:22 | |
|---|---|
| Price | |
| 32.075 EUR | |
| Difference | 2.18% (0.69) |
General attributes
| ISIN | US0718131099 |
| Symbol | BAX |
| Exchange | Berlin |
| Currency | EUR |
| Sector | Chemical / Pharmaceutical / Health |
| Security type | Stock |
| Market cap (m) | 16,618 EUR |
| Benchmark | S&P 500 |
Market data
| Bid (Bid size) | - |
| Ask (Ask size) | - |
| Open | 31.20 EUR |
| High | 32.075 EUR |
| Low | 31.14 EUR |
| Close (prev. day) | 31.39 EUR |
| VWAP | - |
| Volume (pcs) | 0 |
| Trading volume | 0.00 |
| Number of trades | 19 |
| Last size | 0 |
Performance and Risk
| 6m | 1Y | 3Y | |
| Perf (%) | -10.53% | -23.36% | -53.61% |
| Perf (abs.) | -3.78 | -9.78 | -37.07 |
| Beta | 0.43 | 0.55 | 0.57 |
| Volatility | 25.16 | 27.19 | 28.45 |
Add Benchmark:
Price data
| Ø price 5 days | Ø volume 5 days (pcs.) | 31.972 EUR (0) |
| Ø price 30 days | Ø volume 30 days (pcs.) | 31.330 EUR (0) |
| Ø price 100 days | Ø volume 100 days (pcs.) | 34.893 EUR (0) |
| Ø price 250 days | Ø volume 250 days (pcs.) | 35.257 EUR (1) |
| YTD High | date | 41.400 EUR (2024/03/05) |
| YTD Low | date | 30.155 EUR (2024/06/06) |
| 52 Weeks High | date | 44.800 EUR (2023/07/20) |
| 52 Weeks Low | date | 29.550 EUR (2023/10/16) |
All listings for BAXTER INTERNATIONAL INC
| Exchange | Date | Time | Price | Trading volume (mio.) | Number of trades |
| Berlin | 2024/07/16 | 20:30 | 32.075 EUR | 0.00 | 19 |
| Duesseldorf | 2024/07/16 | 19:30 | 31.755 EUR | 0.00 | 7 |
| Euronext Milan MTF Global Equity Market | 2024/07/16 | 17:44 | 31.735 EUR | 0.00 | 1 |
| Euronext Milan MTF Trading After Hours | - | - | - | 0.00 | - |
| Frankfurt | 2024/07/16 | 15:29 | 31.00 EUR | 0.00 | 5 |
| Hamburg | 2024/07/16 | 08:21 | 30.91 EUR | 0.00 | 3 |
| Hanover | 2024/07/16 | 08:21 | 30.91 EUR | 0.00 | 3 |
| London Stock Exchange | 2023/12/12 | 16:52 | 36.35 USD | 0.01 | 1 |
| Munich | 2024/07/16 | 08:00 | 30.925 EUR | 0.00 | 2 |
| NYSE | 2024/07/16 | 22:00 | 35.54 USD | 393.59 | 42,240 |
| Stuttgart | 2024/07/16 | 21:21 | 32.055 EUR | 0.00 | 6 |
| Tradegate | 2024/07/16 | 22:26 | 32.585 EUR | 0.00 | 4 |
| Vienna Stock Exchange | 2024/07/16 | 17:32 | 31.65 EUR | 0.00 | 5 |
Company Logo
Contact Details
| BAXTER INTERNATIONAL INC. |
| - - |
| One Baxter Parkway - 60015-4625 Deerfield |
| Telefon: +1-224-948-2000 |
| Fax: + |
| E-mail: media@baxter.com |
PDF Downloads
| Company report: BAXTER INTERNATIONAL INC | |
Company Profile
Baxter International, Inc. engages in the provision of a portfolio of essential healthcare products including acute and chronic dialysis therapies, sterile intravenous (IV) solutions, infusion systems and devices, parenteral nutrition therapies, inhaled anesthetics, generic injectable pharmaceuticals, surgical hemostat and sealant products, surgical equipment, smart bed systems, patient monitoring and diagnostic technologies, and respiratory health devices. It operates through the following segments: Americas, Europe, Middle East and Africa (EMEA), Asia-Pacific (APAC), and Hillrom. The Americas, EMEA, and APAC segments offer a portfolio of essential healthcare products. The Hillrom segment provides digital and connected care solutions and collaboration tools, including smart bed systems, patient monitoring and diagnostic technologies, respiratory health devices, and equipment for the surgical space. The company was founded by Davis Baxter in 1931 and is headquartered in Deerfield, IL. |
Members of Management Board
| D. Shafer | Member of Board of Directors |
| David Wilkes | Member of Board of Directors |
| Stephen Oesterle | Member of Board of Directors |
| Amy McBride-Wendell | Member of Board of Directors |
| Catherine Smith | Member of Board of Directors |
| Cathy Smith | Member of Board of Directors |
| Nancy Schlichting | Member of Board of Directors |
| Patricia Morrison | Member of Board of Directors |
| Peter Wilver | Member of Board of Directors |
| Stephen Rusckowski | Member of Board of Directors |
| William Ampofo | Member of Board of Directors |
| José (Joe) E. Almeida | Chairman of Managing Board |
| Gerard Greco | Member of Executive Committee |
| James W. Borzi | Member of Executive Committee |
| Jeanne Mason | Member of Executive Committee |
| Joel Grade | Member of Executive Committee |
| Talvis Love | Member of Executive Committee |
| Tobi Karchmer | Member of Executive Committee |